| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 98,408 | 92,110 | 86,448 | 85,021 | | Cost of Revenue | 29,398 | 26,466 | 26,211 | 26,117 | | | Gross Profit | 69,010 | 65,644 | 60,237 | 58,904 | | | Operating Expenses | | Research Development | 11,803 | 11,218 | 10,827 | 10,389 | | Selling General and Administrative | 38,931 | 40,010 | 37,543 | 36,203 | | Non Recurring |
-
| 10,984 |
-
|
-
| | Others | 9,282 | 7,861 | 8,585 | 9,729 | | | | Total Operating Expenses |
-
| 70,073 |
-
|
-
| | | | Operating Income or Loss | 8,994 | (4,429) | 3,282 | 2,583 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 336 | 1,420 | (451) | 673 | | Earnings Before Interest And Taxes | 9,330 | (3,009) | 2,831 | 3,256 | | Interest Expense | 3,015 | 2,971 | 2,891 | 1,760 | | Income Before Tax | 6,315 | (5,980) | (60) | 1,496 | | Income Tax Expense | 2,007 | (1,907) | (23) | (1,489) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,308 | (4,073) | (37) | 2,985 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,308 | (4,073) | (37) | 2,985 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,308 | ($4,073) | ($37) | $2,985 |
|
0.51% Nasdaq 
Income Statement
